Skip Navigation

European Heart Journal 1995 16(12):1773-1779;
Copyright © 1995 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by PATEL, D. J.
Right arrow Articles by FOX, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by PATEL, D. J.
Right arrow Articles by FOX, K. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 The European Society of Cardiology

Does the exercise protocol matter when assessing the anti-anginal effects of drug therapy?

D. J. PATEL, D. MULCAHY, J. NORRIE*, J. SPARROW, C. WRIGHT, I. FORD* and K. M. FOX

Department of Cardiology, Royal Brompton Hospital, University of Glasgow U.K.
*The Robertson Centre for Biostatistics, University of Glasgow U.K.

revised 4 January 1995; accepted 18 January 1995.

Correspondence: Deven J. Patel, Department of Cardiology, Royal Brompton Hospital, Sydney Street, London SW3, 6NP, U K

Abstract

Four exercise test protocols (Bruce, Balke, Ellestad and Steep) were compared in 16 patients with proven coronary artery disease in demonstrating the anti-anginal effects of sublingual glyceryl trinitrate in a randomization double-blind trial.

Glyceryl trinitrate significantly improved the time, heart rate and rate pressure product to peak exercise, onset of angina and 1 mm ST segment depression in all four protocols (P<0.05) (except rate pressure product to angina in the Balke protocol). The increase in exercise time was greatest for the Balke protocol at peak exercise (188.1±187.1) (mean±SD in s), at onset of angina (251.9±247.1) and at 1 mm ST depression (233.6±243.8), followed by the Steep and Bruce protocols, and was lowest for the Ellestad protocol 41.9±42.4, 96.5±65.8, 82.6±74.0, respectively. Increase in time to peak exercise with glyceryl trinitrate was significantly greater for the Balke protocol in comparison with the other three protocols and for the Bruce and Steep protocols when compared to the Ellestad protocol. Time to 1 mm ST depression with treatment was significantly greater on the Balke and Bruce protocols than the Ellestad protocol, and to onset of angina for the Balke compared to other three protocols. There were no significant differences between the Bruce and Steep protocols for any of the endpoints. The magnitude of treatment effect in the different protocols was accompanied by correspondingly greater inter-patient variability such that no protocol was more, or less, sensitive than another in detecting treatment effect. Changes in heart rate and rate pressure product with treatment were generally similar between the different protocols.

In conclusion, a protocol with small and frequent increments (Balke), although able to show greater increase in exercise duration with glyceryl trinitrate than more aggressive protocols, is no more sensitive at detecting treatment effect.

Key Words: Exercise test • angina pectoris • exercise protocol • drug therapy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
R. A. H. Stewart, J. Kittelson, and I. P. Kay
Statistical methods to improve the precision of the treadmill exercise test
J. Am. Coll. Cardiol., October 1, 2000; 36(4): 1274 - 1279.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.